drugset / Trial / NCT02631863

Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)

NCT02631863 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This trial will study the effectiveness of photodynamic therapy with aminolaevulinic acid for the treatment of patients with HPV+ low grade cervical intraepithelial neoplasia (LSIL;CIN1).

Timeline

Start
2016-03-22
Primary completion
2018-11-24
Completion
2018-11-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminolaevulinic acid Unknown 500 mg Topical